Skip to content

Effect of Electroconvulsive Therapy on Retinal Nerve Fiber Layer Thickness in Depression

Can Electroconvulsive Therapy Alter Retinal Nerve Fiber Layer Thickness of Patients With Depression

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04305132
Enrollment
50
Registered
2020-03-12
Start date
2020-01-01
Completion date
2021-09-30
Last updated
2021-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Keywords

depression, electroconvulsive therapy, retinal nerve fiber layer, optical coherence tomography

Brief summary

The aim of this study is to investigate the changes in the retinal nerve fiber layer thickness of the patients with depression who received electroconvulsive therapy by means of optical coherence tomography.

Detailed description

Major depression (MD) is a mood disorder that is common in the society, has negative effects on emotion, thought and behavior, and leads to significant impairments in functionality. Electroconvulsive therapy (ECT) is a highly effective and reliable biological treatment method used in psychiatric diseases for a long time. The most common use in psychiatry is depression. Studies have shown that ECT causes a broadly distributed increase in brain gray matter volume (especially the temporal lobe) in MD patients. Optical coherence tomography (OCT) is a non-invasive medical imaging method that displays biological tissue layers by taking high resolution tomographic sections. Alterations in the thickness of the retinal nerve fiber layer (RNFL), which is a layer of the ganglion cell complex in the retina of the eye and consists of ganglion cell axons, occur due to axonal damage in the retinal nerve tissue. Since RNFL is in a similar form with the brain gray matter tissue, recently, neurological and psychiatric studies have been conducted to provide data regarding the neurodegeneration occurring in the brain tissue. In the study, it is aimed to assess the possible cortical volume changes of patients by measuring changes in the retinal layers due to ECT in patients with depression. In other words, considering that ECT causes an increase in brain volume, it is to observe whether this increase is reflected in the retinal nerve fiber layer thickness.

Interventions

DEVICEElectroconvulsive therapy

Thymatron System IV electroconvulsive therapy device

Sponsors

Mehmet Diyaddin Güleken
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Subject diagnosed as unipolar depression * Subject with depression to be treated with electroconvulsive therapy * Subject with depression having a Standardized Mini Mental Test score of \>23

Exclusion criteria

* Any comorbid psychiatric condition (including alcohol / substance use) * Having any major neurological (i.e.: cerebrovascular disease, multiple sclerosis, etc.) disease * Having any major medical (i.e.: diabetes mellitus, myocardial infarction, etc.) disease * History of or having any ocular trauma, disease or surgery, any retinal disease, refraction defect * To be treated with electroconvulsive therapy in the last 6 months

Design outcomes

Primary

MeasureTime frameDescription
Changes of retinal nerve fiber layer thicknessAbout 4 weeksChanges of retinal nerve fiber layer thickness of subjects with depression before and after electroconvulsive therapy

Countries

Turkey (Türkiye)

Contacts

Primary ContactMehmet D Güleken, MD
mdguleken@hotmail.com+905063282603
Backup ContactHasan Öncül, MD
hasan.oncul@hotmail.com+905357624011

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026